Panagiota Spanou

Panagiota Spanou is an experienced professional in the field of regulatory affairs and product development within the pharmaceutical industry. At KLEVA Pharmaceuticals S.A., Panagiota served as a Senior Regulatory Affairs Officer, focusing on compliance with international legislation, managing national registration procedures for marketing authorizations, and lifecycle management of products. Prior to this role, Panagiota worked as a Product Development-CMC Officer at KLEVA, where responsibilities included updating pharmaceutical product dossiers and ensuring compliance with ICH and EMA guidelines. From February 2019 to October 2023, Panagiota was a Regulatory Affairs Officer at Elpen Pharmaceutical Co. Inc., keeping abreast of regulatory changes and communicating with clients on various projects. Early career experience includes an internship at the University of Patras, where Panagiota conducted research in pharmacology. Educational qualifications include a Master's degree in Clinical Drug Development from Queen Mary University of London and a Bachelor's degree in Biology from the University of Patras.